Hims vs WeightWatchers (Sequence): Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

48 providers verified independently·Independent research·How we rank →

Hims beats WeightWatchers (Sequence) overall, scoring 7.9/10 vs 7.4/10. Hims is more affordable at $199/mo vs $423/mo. Choose Hims for men who want a well-known publicly-traded brand and fda-appr. Choose WeightWatchers (Sequence) for users who want glp-1 medication combined with the weightwatc.

A side-by-side comparison of Hims and WeightWatchers (Sequence) covering pricing, scores, medication types, insurance, and more to help you decide.

Higher Rated

Hims

#12 of 48

7.9/10

The household name in men's telehealth, publicly traded as Hims & Hers Health (NYSE: HIMS). In 2026 Hims added FDA-approved brand-name Wegovy (injection and pill) and Ozempic through a direct Novo Nordisk partnership — alongside their existing compounded semaglutide program. Brand recognition and product breadth are real strengths. The trade-off: Hims' verified Trustpilot rating is 3.0 stars across 8,286 reviews (May 2026) — significantly below smaller competitors like Henry Meds (4.5) or Eden Health (4.5). The 1-star pool is 28% — the highest 1-star rate in our table — clustered around subscription/billing complaints.

Visit Hims

WeightWatchers (Sequence)

#29 of 48

7.4/10

WeightWatchers' clinical weight management arm (acquired from Sequence). Membership is tiered: 12-month plan first month $149-$299 depending on tier, then $74/mo ongoing for months 2-12; shorter plans are higher per-month. Medication billed separately: $199/mo intro for 2 months, then $349/mo ongoing. Lineup includes Saxenda (liraglutide brand), Wegovy, Zepbound, and compounded semaglutide/tirzepatide.

Visit WeightWatchers (Sequence)

Feature	Hims	WeightWatchers (Sequence)
Our Score	7.9/10	7.4/10
Starting Price	$199/mo	$423/mo
Medication Type	Both	Both
Insurance Accepted	No	Yes
Best For	Men who want a well-known publicly-traded brand and FDA-approved Wegovy through the 2026 Novo Nordisk partnership — but should know going in that Hims' customer-experience signal is weaker than smaller competitors	Users who want GLP-1 medication combined with the WeightWatchers program and community — $74 ongoing membership (on 12-month plan, $149-$299 first month) + $349 ongoing medication = $423/mo all-in
Ranking	#12	#29

Pros & Cons Compared

Hims

Pros

+Publicly traded company (NYSE: HIMS) — SEC-filed financials, regulatory accountability that private competitors don't have.
+2026 Novo Nordisk partnership — FDA-approved Wegovy injection, Wegovy pill, and Ozempic now available directly through Hims. Real brand-name access from a single platform.
+$199/mo all-inclusive for compounded semaglutide, including consultations and shipping.
+Polished app and web experience — among the best user interfaces in men's telehealth.
+8,286 verified Trustpilot reviews is the second-largest review volume in our table (after Henry's 12,461) — significant real-world adoption.

Cons

−Trustpilot rating is 3.0 stars / 8,286 reviews (May 2026) — significantly below Henry Meds (4.5), Eden Health (4.5), Yucca Health (4.6), MEDVi (4.4). The lowest customer-experience signal of any major brand we track.
−28% of Trustpilot reviews are 1-star — the highest 1-star rate in our table. Top complaint themes: subscription handling, unexpected charges, customer service responsiveness.
−Hims reviews span ALL their products (ED, hair loss, mental health, weight loss) — not just GLP-1. But the rating still applies because most users don't separate experiences by product.
−'Hims Oral Kit' is NOT a GLP-1 — it's a non-GLP-1 metabolic combination (metformin + bupropion + topiramate + B12 + naltrexone). Easy to confuse with their compounded semaglutide. Read the product page carefully before signing up.
−Brand Wegovy at $599/mo is not competitive with LillyDirect/NovoCare cash prices or with Hers ($149/mo for the same product via the same Novo partnership).
−Generic high-volume support — large patient base means less personalized attention than smaller competitors.

WeightWatchers (Sequence)

Pros

+Combines GLP-1 medication with WeightWatchers' proven points system and community support
+Insurance accepted for medication — can reduce costs significantly with qualifying plans
+Decades of brand trust and weight loss expertise applied to clinical medication management
+Access to WW community, workshops, and digital tools alongside medication

Cons

−$269/mo without insurance is expensive for what's included clinically
−The WW program integration adds complexity that medication-only users won't value
−The Sequence acquisition is still integrating — some operational inconsistencies remain
−Less medication flexibility than pure-play GLP-1 platforms

Our Verdict

Hims edges out WeightWatchers (Sequence) with a score of 7.9/10 vs 7.4/10. If budget is your priority, Hims starts at $199/mo compared to WeightWatchers (Sequence)'s $423/mo. WeightWatchers (Sequence) accepts insurance, which can significantly reduce your out-of-pocket costs. Choose Hims if you want: men who want a well-known publicly-traded brand and fda-approved wegovy through the 2026 novo nordisk partnership — but should know going in that hims' customer-experience signal is weaker than smaller competitors. Choose WeightWatchers (Sequence) if you want: users who want glp-1 medication combined with the weightwatchers program and community — $74 ongoing membership (on 12-month plan, $149-$299 first month) + $349 ongoing medication = $423/mo all-in.

Still undecided? Editor's #1 Overall Pick

Embody

$299/mo · 7.3/10 · Compounded

If neither Hims nor WeightWatchers (Sequence) feels like the right fit, our overall #1 pick across all 48 GLP-1 telehealth providers is Embody — strongest balance of clinical oversight, transparent pricing, and verified availability.

Visit Embody→Read our full Embody review